AN2-502998

N/A

Report date: 2025/06/19 20:00:08
NME

Base Information

Drug NameAN2-502998
Drug Alias NameAN15368AN-15368AN2-502998
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCleavage and polyadenylation specificity factor subunit 3 inhibitors
TargetsCleavage and polyadenylation specificity factor subunit 3
Therapy Area/IndicationsChagas Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAnacor Pharmaceuticals IncUniversity of Georgia Research Foundation Inc
China Registration ClassN/A

Develop Information

Active CompaniesAN2 Therapeutics IncAn2 TherapeuticsAnacor Pharmaceuticals Inc +[4] 
Inactive CompaniesN/A
Active IndicationsChagas Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A